CONTENTS

4 OVERVIEW

4 Drug Overview

5 Product Profiles

5 Juluca : HIV

LIST OF FIGURES

10 Figure 58: Datamonitor Healthcare's drug assessment summary of cabotegravir/rilpivirine for HIV

11 Figure 59: Cabotegravir/rilpivirine sales for HIV across the US and five major EU markets, by country, 2018-27

13 Figure 60: Datamonitor Healthcare's drug assessment summary of fostemsavir for HIV

LIST OF TABLES

6 Table 1: Juluca drug profile

7 Table 2: Approval history of Juluca for HIV in the US, Japan, and five major EU markets

8 Table 3: Late-phase trials of Juluca for HIV
9 Table 4: Juluca for HIV - SWOT analysis